Immune Tolerance Network — GERALD T NEPOM (BENAROYA RESEARCH INST AT VIRGINIA MASON)
Project Summary/Abstract: Anti CD14 (CaTT) The SARS-CoV-2 pandemic continues to spread around the world, causing widespread illness with significant mortality, overburdening health care systems and di
| Project title | Immune Tolerance Network |
|---|---|
| Project number | 3UM1AI109565-07S1 |
| PI name | GERALD T NEPOM |
| Institution | BENAROYA RESEARCH INST AT VIRGINIA MASON |
| Funding mechanism | UM1 |
| Agency | NIAID |
| Award amount | $2.30M |
| Fiscal year | 2021 |
| Project start | 2020-12-30T00:00:00 |
| Project end | 2022-05-31T00:00:00 |
| Abstract | Project Summary/Abstract: Anti CD14 (CaTT) The SARS-CoV-2 pandemic continues to spread around the world, causing widespread illness with significant mortality, overburdening health care systems and di |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Antibody Therapy><Antiviral Ag |
$799/mo
Try GrantRadar →